アデノシンデアミナーゼ欠損症治療薬世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > アデノシンデアミナーゼ欠損症治療薬世界市場の発展状況と動向 2024-2030

英文タイトル： Global Adenosine Deaminase Deficiency Drugs Market Insights, Forecast to 2030

レポートID：269691
発表時期：2024-04-25
訪問回数：740
ページ数：71
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：105
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、アデノシンデアミナーゼ欠損症治療薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にアデノシンデアミナーゼ欠損症治療薬市場を分類しています。

本レポートでは世界のアデノシンデアミナーゼ欠損症治療薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Leadiant Biosciences、Chiesi

レポートはアデノシンデアミナーゼ欠損症治療薬の主要生産者を調査し、主要地域や国の消費状況も提供します。アデノシンデアミナーゼ欠損症治療薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Adagen
Revcovi

用途別の市場セグメント：
Hospital
Pharmacy

本レポートの詳細内容
本レポートは、世界のアデノシンデアミナーゼ欠損症治療薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてアデノシンデアミナーゼ欠損症治療薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のアデノシンデアミナーゼ欠損症治療薬生産量、成長率、市場シェアを調査している。

二. 消費面では、アデノシンデアミナーゼ欠損症治療薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのアデノシンデアミナーゼ欠損症治療薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のアデノシンデアミナーゼ欠損症治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本アデノシンデアミナーゼ欠損症治療薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：アデノシンデアミナーゼ欠損症治療薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：アデノシンデアミナーゼ欠損症治療薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるアデノシンデアミナーゼ欠損症治療薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章アデノシンデアミナーゼ欠損症治療薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：アデノシンデアミナーゼ欠損症治療薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：アデノシンデアミナーゼ欠損症治療薬の主要メーカーの概要を提供し、製品の説明と仕様、アデノシンデアミナーゼ欠損症治療薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：アデノシンデアミナーゼ欠損症治療薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.
The global Adenosine Deaminase Deficiency Drugs market is projected to grow from US$ 136 million in 2024 to US$ 174.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.
The market driver for Adenosine Deaminase Deficiency (ADA) therapeutic products is the critical need to address this rare and life-threatening genetic disorder. ADA-SCID severely compromises the immune system, making effective treatment essential. Gene therapies and enzyme replacement therapies have shown promise in restoring immune function, driving market growth. However, challenges include limited patient population, high treatment costs, and the need for early and accurate diagnosis. Additionally, access to these specialized therapies and regulatory hurdles pose challenges. Despite challenges, the ADA therapeutic market presents opportunities for further research and development, offering hope for improved outcomes for patients with this devastating condition.
Report Covers:
This report presents an overview of global market for Adenosine Deaminase Deficiency Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Adenosine Deaminase Deficiency Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Adenosine Deaminase Deficiency Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adenosine Deaminase Deficiency Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adenosine Deaminase Deficiency Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adenosine Deaminase Deficiency Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Leadiant Biosciences and Chiesi etc.

Market Segmentation
By Company
Leadiant Biosciences
Chiesi

Segment by Type
Adagen
Revcovi

Segment by Application
Hospital
Pharmacy

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Adenosine Deaminase Deficiency Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Adenosine Deaminase Deficiency Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adenosine Deaminase Deficiency Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Adenosine Deaminase Deficiency Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Adagen
1.2.3 Revcovi
1.3 Market by Application
1.3.1 Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Adenosine Deaminase Deficiency Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Adenosine Deaminase Deficiency Drugs Revenue by Region
2.2.1 Global Adenosine Deaminase Deficiency Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Adenosine Deaminase Deficiency Drugs Revenue by Region (2019-2024)
2.2.3 Global Adenosine Deaminase Deficiency Drugs Revenue by Region (2025-2030)
2.2.4 Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Adenosine Deaminase Deficiency Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Adenosine Deaminase Deficiency Drugs Sales by Region
2.4.1 Global Adenosine Deaminase Deficiency Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Adenosine Deaminase Deficiency Drugs Sales by Region (2019-2024)
2.4.3 Global Adenosine Deaminase Deficiency Drugs Sales by Region (2025-2030)
2.4.4 Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Adenosine Deaminase Deficiency Drugs Sales by Manufacturers
3.1.1 Global Adenosine Deaminase Deficiency Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Adenosine Deaminase Deficiency Drugs in 2023
3.2 Global Adenosine Deaminase Deficiency Drugs Revenue by Manufacturers
3.2.1 Global Adenosine Deaminase Deficiency Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Adenosine Deaminase Deficiency Drugs Revenue in 2023
3.3 Global Key Players of Adenosine Deaminase Deficiency Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Adenosine Deaminase Deficiency Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Adenosine Deaminase Deficiency Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Adenosine Deaminase Deficiency Drugs Sales by Type
4.1.1 Global Adenosine Deaminase Deficiency Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Adenosine Deaminase Deficiency Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
4.2 Global Adenosine Deaminase Deficiency Drugs Revenue by Type
4.2.1 Global Adenosine Deaminase Deficiency Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Adenosine Deaminase Deficiency Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Adenosine Deaminase Deficiency Drugs Price by Type
4.3.1 Global Adenosine Deaminase Deficiency Drugs Price by Type (2019-2024)
4.3.2 Global Adenosine Deaminase Deficiency Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Adenosine Deaminase Deficiency Drugs Sales by Application
5.1.1 Global Adenosine Deaminase Deficiency Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Adenosine Deaminase Deficiency Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
5.2 Global Adenosine Deaminase Deficiency Drugs Revenue by Application
5.2.1 Global Adenosine Deaminase Deficiency Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Adenosine Deaminase Deficiency Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Adenosine Deaminase Deficiency Drugs Price by Application
5.3.1 Global Adenosine Deaminase Deficiency Drugs Price by Application (2019-2024)
5.3.2 Global Adenosine Deaminase Deficiency Drugs Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Adenosine Deaminase Deficiency Drugs Market Size by Type
6.1.1 US & Canada Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2030)
6.2 US & Canada Adenosine Deaminase Deficiency Drugs Market Size by Application
6.2.1 US & Canada Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2030)
6.3 US & Canada Adenosine Deaminase Deficiency Drugs Market Size by Country
6.3.1 US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Adenosine Deaminase Deficiency Drugs Market Size by Type
7.1.1 Europe Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2030)
7.1.2 Europe Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2030)
7.2 Europe Adenosine Deaminase Deficiency Drugs Market Size by Application
7.2.1 Europe Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2030)
7.2.2 Europe Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2030)
7.3 Europe Adenosine Deaminase Deficiency Drugs Market Size by Country
7.3.1 Europe Adenosine Deaminase Deficiency Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2030)
7.3.3 Europe Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Adenosine Deaminase Deficiency Drugs Market Size
8.1.1 China Adenosine Deaminase Deficiency Drugs Sales (2019-2030)
8.1.2 China Adenosine Deaminase Deficiency Drugs Revenue (2019-2030)
8.2 China Adenosine Deaminase Deficiency Drugs Market Size by Application
8.2.1 China Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2030)
8.2.2 China Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Adenosine Deaminase Deficiency Drugs Market Size by Type
9.1.1 Asia Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2030)
9.1.2 Asia Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2030)
9.2 Asia Adenosine Deaminase Deficiency Drugs Market Size by Application
9.2.1 Asia Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2030)
9.2.2 Asia Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2030)
9.3 Asia Adenosine Deaminase Deficiency Drugs Sales by Region
9.3.1 Asia Adenosine Deaminase Deficiency Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Adenosine Deaminase Deficiency Drugs Revenue by Region (2019-2030)
9.3.3 Asia Adenosine Deaminase Deficiency Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Leadiant Biosciences
11.1.1 Leadiant Biosciences Company Information
11.1.2 Leadiant Biosciences Overview
11.1.3 Leadiant Biosciences Adenosine Deaminase Deficiency Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Leadiant Biosciences Adenosine Deaminase Deficiency Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Leadiant Biosciences Recent Developments
11.2 Chiesi
11.2.1 Chiesi Company Information
11.2.2 Chiesi Overview
11.2.3 Chiesi Adenosine Deaminase Deficiency Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Chiesi Adenosine Deaminase Deficiency Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chiesi Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Adenosine Deaminase Deficiency Drugs Industry Chain Analysis
12.2 Adenosine Deaminase Deficiency Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Adenosine Deaminase Deficiency Drugs Production Mode & Process
12.4 Adenosine Deaminase Deficiency Drugs Sales and Marketing
12.4.1 Adenosine Deaminase Deficiency Drugs Sales Channels
12.4.2 Adenosine Deaminase Deficiency Drugs Distributors
12.5 Adenosine Deaminase Deficiency Drugs Customers

13 Market Dynamics
13.1 Adenosine Deaminase Deficiency Drugs Industry Trends
13.2 Adenosine Deaminase Deficiency Drugs Market Drivers
13.3 Adenosine Deaminase Deficiency Drugs Market Challenges
13.4 Adenosine Deaminase Deficiency Drugs Market Restraints

14 Key Findings in The Global Adenosine Deaminase Deficiency Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Adagen
    Table 3. Major Manufacturers of Revcovi
    Table 4. Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Adenosine Deaminase Deficiency Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Adenosine Deaminase Deficiency Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Adenosine Deaminase Deficiency Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Region (2019-2024)
    Table 9. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Region (2025-2030)
    Table 10. Global Adenosine Deaminase Deficiency Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Adenosine Deaminase Deficiency Drugs Sales by Region (2019-2024) & (Units)
    Table 12. Global Adenosine Deaminase Deficiency Drugs Sales by Region (2025-2030) & (Units)
    Table 13. Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Region (2019-2024)
    Table 14. Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Region (2025-2030)
    Table 15. Global Adenosine Deaminase Deficiency Drugs Sales by Manufacturers (2019-2024) & (Units)
    Table 16. Global Adenosine Deaminase Deficiency Drugs Sales Share by Manufacturers (2019-2024)
    Table 17. Global Adenosine Deaminase Deficiency Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Adenosine Deaminase Deficiency Drugs Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Adenosine Deaminase Deficiency Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Adenosine Deaminase Deficiency Drugs Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Adenosine Deaminase Deficiency Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Adenosine Deaminase Deficiency Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency Drugs as of 2023)
    Table 23. Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Product Offered and Application
    Table 25. Global Key Manufacturers of Adenosine Deaminase Deficiency Drugs, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 28. Global Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 29. Global Adenosine Deaminase Deficiency Drugs Sales Share by Type (2019-2024)
    Table 30. Global Adenosine Deaminase Deficiency Drugs Sales Share by Type (2025-2030)
    Table 31. Global Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Adenosine Deaminase Deficiency Drugs Revenue Share by Type (2019-2024)
    Table 34. Global Adenosine Deaminase Deficiency Drugs Revenue Share by Type (2025-2030)
    Table 35. Adenosine Deaminase Deficiency Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Adenosine Deaminase Deficiency Drugs Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 38. Global Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 39. Global Adenosine Deaminase Deficiency Drugs Sales Share by Application (2019-2024)
    Table 40. Global Adenosine Deaminase Deficiency Drugs Sales Share by Application (2025-2030)
    Table 41. Global Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Adenosine Deaminase Deficiency Drugs Revenue Share by Application (2019-2024)
    Table 44. Global Adenosine Deaminase Deficiency Drugs Revenue Share by Application (2025-2030)
    Table 45. Adenosine Deaminase Deficiency Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Adenosine Deaminase Deficiency Drugs Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 48. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 49. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 52. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 53. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Adenosine Deaminase Deficiency Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Adenosine Deaminase Deficiency Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2024) & (Units)
    Table 59. US & Canada Adenosine Deaminase Deficiency Drugs Sales by Country (2025-2030) & (Units)
    Table 60. Europe Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 61. Europe Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 62. Europe Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 65. Europe Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 66. Europe Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Adenosine Deaminase Deficiency Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Adenosine Deaminase Deficiency Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2024) & (Units)
    Table 72. Europe Adenosine Deaminase Deficiency Drugs Sales by Country (2025-2030) & (Units)
    Table 73. China Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 74. China Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 75. China Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 78. China Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 79. China Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 82. Asia Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 83. Asia Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 86. Asia Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 87. Asia Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Adenosine Deaminase Deficiency Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Adenosine Deaminase Deficiency Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Adenosine Deaminase Deficiency Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Adenosine Deaminase Deficiency Drugs Sales by Region (2019-2024) & (Units)
    Table 93. Asia Adenosine Deaminase Deficiency Drugs Sales by Region (2025-2030) & (Units)
    Table 94. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Type (2019-2024) & (Units)
    Table 95. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Type (2025-2030) & (Units)
    Table 96. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Application (2019-2024) & (Units)
    Table 99. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Application (2025-2030) & (Units)
    Table 100. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Country (2019-2024) & (Units)
    Table 106. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales by Country (2025-2030) & (Units)
    Table 107. Leadiant Biosciences Company Information
    Table 108. Leadiant Biosciences Description and Major Businesses
    Table 109. Leadiant Biosciences Adenosine Deaminase Deficiency Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Leadiant Biosciences Adenosine Deaminase Deficiency Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Leadiant Biosciences Recent Developments
    Table 112. Chiesi Company Information
    Table 113. Chiesi Description and Major Businesses
    Table 114. Chiesi Adenosine Deaminase Deficiency Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Chiesi Adenosine Deaminase Deficiency Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Chiesi Recent Developments
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Adenosine Deaminase Deficiency Drugs Distributors List
    Table 120. Adenosine Deaminase Deficiency Drugs Customers List
    Table 121. Adenosine Deaminase Deficiency Drugs Market Trends
    Table 122. Adenosine Deaminase Deficiency Drugs Market Drivers
    Table 123. Adenosine Deaminase Deficiency Drugs Market Challenges
    Table 124. Adenosine Deaminase Deficiency Drugs Market Restraints
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Adenosine Deaminase Deficiency Drugs Product Picture
    Figure 2. Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Adenosine Deaminase Deficiency Drugs Market Share by Type in 2023 & 2030
    Figure 4. Adagen Product Picture
    Figure 5. Revcovi Product Picture
    Figure 6. Global Adenosine Deaminase Deficiency Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Adenosine Deaminase Deficiency Drugs Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Pharmacy
    Figure 10. Adenosine Deaminase Deficiency Drugs Report Years Considered
    Figure 11. Global Adenosine Deaminase Deficiency Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Adenosine Deaminase Deficiency Drugs Revenue 2019-2030 (US$ Million)
    Figure 13. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Region (2019-2030)
    Figure 15. Global Adenosine Deaminase Deficiency Drugs Sales 2019-2030 ((Units)
    Figure 16. Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Adenosine Deaminase Deficiency Drugs Sales YoY (2019-2030) & (Units)
    Figure 18. US & Canada Adenosine Deaminase Deficiency Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Adenosine Deaminase Deficiency Drugs Sales YoY (2019-2030) & (Units)
    Figure 20. Europe Adenosine Deaminase Deficiency Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Adenosine Deaminase Deficiency Drugs Sales YoY (2019-2030) & (Units)
    Figure 22. China Adenosine Deaminase Deficiency Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Adenosine Deaminase Deficiency Drugs Sales YoY (2019-2030) & (Units)
    Figure 24. Asia (excluding China) Adenosine Deaminase Deficiency Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales YoY (2019-2030) & (Units)
    Figure 26. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Adenosine Deaminase Deficiency Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Adenosine Deaminase Deficiency Drugs in the World: Market Share by Adenosine Deaminase Deficiency Drugs Revenue in 2023
    Figure 29. Global Adenosine Deaminase Deficiency Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 31. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 32. Global Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 33. Global Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Adenosine Deaminase Deficiency Drugs Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Adenosine Deaminase Deficiency Drugs Sales Share by Country (2019-2030)
    Figure 40. U.S. Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 43. Europe Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 45. Europe Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Adenosine Deaminase Deficiency Drugs Revenue Share by Country (2019-2030)
    Figure 47. Europe Adenosine Deaminase Deficiency Drugs Sales Share by Country (2019-2030)
    Figure 48. Germany Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 49. France Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 50. UK Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. China Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 54. China Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 55. China Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 56. China Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 58. Asia Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 60. Asia Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Adenosine Deaminase Deficiency Drugs Revenue Share by Region (2019-2030)
    Figure 62. Asia Adenosine Deaminase Deficiency Drugs Sales Share by Region (2019-2030)
    Figure 63. Japan Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. India Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Adenosine Deaminase Deficiency Drugs Sales Share by Country (2019-2030)
    Figure 74. Brazil Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Adenosine Deaminase Deficiency Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. Adenosine Deaminase Deficiency Drugs Value Chain
    Figure 80. Adenosine Deaminase Deficiency Drugs Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed

産業カテゴリー